GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MEI Pharma Inc (LTS:0JW9) » Definitions » Pre-Tax Income

MEI Pharma (LTS:0JW9) Pre-Tax Income : $-46.60 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is MEI Pharma Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. MEI Pharma's pretax income for the three months ended in Sep. 2024 was $-8.01 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-46.60 Mil. MEI Pharma's pretax margin was %.

During the past 13 years, MEI Pharma's highest Pretax Margin was 27.23%. The lowest was -2470.22%. And the median was -126.26%.


MEI Pharma Pre-Tax Income Historical Data

The historical data trend for MEI Pharma's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEI Pharma Pre-Tax Income Chart

MEI Pharma Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -47.17 -41.31 -54.45 -31.84 17.78

MEI Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.37 -11.06 -9.13 -18.41 -8.01

Competitive Comparison of MEI Pharma's Pre-Tax Income

For the Biotechnology subindustry, MEI Pharma's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEI Pharma's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MEI Pharma's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where MEI Pharma's Pre-Tax Income falls into.



MEI Pharma Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

MEI Pharma's Pretax Income for the fiscal year that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=25.441+-10.94+0+3.277+0
=17.78

MEI Pharma's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-8.352+-0.01+0+0.355+0
=-8.01

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-46.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MEI Pharma  (LTS:0JW9) Pre-Tax Income Explanation

MEI Pharma's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-8.007/0
=%

During the past 13 years, MEI Pharma's highest Pretax Margin was 27.23%. The lowest was -2470.22%. And the median was -126.26%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MEI Pharma Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of MEI Pharma's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


MEI Pharma Business Description

Traded in Other Exchanges
Address
9920 Pacific Heights Blvd, Suite 150, San Diego, CA, USA, 92121
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

MEI Pharma Headlines

No Headlines